Request for Proposal (RFP) for the Execution of Coverage Survey for Seasonal Malaria Chemoprevention at Malaria Consortium Nigeria

Posted by Future on Thu 19th Aug, 2021 - nigeriantenders.com


Malaria Consortium Nigeria invites reputable and qualified research and health institutions to indicate interest by submitting RFQ documents to tender for the following works:




Malaria Consortium is one of the world’s leading non-profit organisations dedicated to the comprehensive control of malaria and other communicable diseases in Africa and Southeast Asia. 

Malaria Consortium works with communities, government and non-government agencies academic institutions, and local and international organisations, to ensure good evidence supports delivery of effective services, providing technical support for monitoring and evaluation of programmes and activities for evidence-based decision-making and strategic planning, The organisation works to improve not only the health of the individual, but also the capacity of national health systems, which helps relieve poverty and support improved economic prosperity.

Malaria Consortium is committed to obtaining a fair value for services received with a competitive price and timely delivery of the right quantities at the right quality.

Applications are invited for:

Title: Request for Proposal (RFP) for the Execution of Coverage Survey for Seasonal Malaria Chemoprevention

Preamble
It is the intent of this RFP to secure competitive proposals from research institution with experience in public health quantitative research, especially epidemiological surveys, to carry out a coverage survey for its seasonal malaria chemoprevention (SMC) programme in Nigeria.

Scope of Work
Malaria Consortium has been implementing seasonal malaria chemoprevention (SMC) programs in northern Nigeria since 2013, and the coverage survey will be conducted in the following States of Bauchi,Borno, Kano, Kebbi, Kogi, Nasarawa, Plateau and Sokoto.

The SMC protocol requires four to five cycles of drugs distribution, overlapping the rainy season when mosquitoes are most active and transmission is highest. During a drug distribution cycle all households in the states must be visited with all children under 5 treated at each cycle. This represents approximately 10 million children aged 3 to 59 months, receiving anti-malaria drugs (SPAQ) monthly, between July and November. This survey is planned to assess 2021 coverage of SMC in the eight (8) states as listed above, as well as the quality of implementation of the 2021 round (a round is when all 4-5 cycles are completed for a specific year) and the overall SMC campaign. More specifically, the survey will make it possible to:
  • Assess self-reported SMC coverage among the targeted population 
  • Identify the main factors associated with community drugs distributors’ visits and treatment administration during the round of SMC
  • Measure adherence to the SMC protocol by the caregivers and community drug distributors (CDDs)
  • Highlight the most common source of information on SMC
  • Measure the degree of information given to mothers/ caregivers on what to do in case of adverse drug reaction to SMC.
Application Closing Date
17:00pm Tuesday, 31st August, 2021.





Submission of Documents
Vendors shall submit offers electronically to: tenders@malariaconsortium.org and in the subject field state the following: MC-SMC-2021-CS-NG

Note
  • Bids received after the deadline will NOT be accepted.
  • Questions must be sent by email to: tenders@malariaconsortium.org with the following bid reference in the subject: MC-SMC-2021-CS-NG - Question". 
  • Responses to requests for clarification shall not materially change any of the elements of the proposals submitted. Unsolicited communications from Tenderers will not be entertained during the evaluation period. 
  • All questions must be submitted by 14th of August, 2021.
For detailed description of the Request for Proposal (RFP), Bidder Response Document (BRD), please Click here (MS WORD)

Related Documents (Annexes)
General
  • The Supplier shall not use the Customer’s name, branding or logo other than in accordance with the Customer's written instructions or authorisation.
  • The Supplier may not assign, transfer, charge, subcontract, novate or deal in any other manner with any or all of its rights or obligations under the Contract without the Customer’s prior written consent.
  • Any notice under or in connection with the Contract shall be given in writing to the address specified in the Order or to such other address as shall be notified in writing from time to time.  For the purposes of this Condition, "writing" shall include e-mails and faxes. 
  • If any court or competent authority finds that any provision of the Contract (or part of any provision) is invalid, illegal or unenforceable, that provision or part-provision shall, to the extent required, be deemed to be deleted, and the validity and enforce-ability of the other provisions of the Contract shall not be affected.
  • Any variation to the Contract, including the introduction of any additional terms and conditions, shall only be binding when agreed in writing and signed by both parties. 
  • The Contract shall be governed by and construed in accordance with English law. The parties irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute or claim arising out of or in connection with the Contract or its subject matter or formation. 
  • A person who is not a party to the Contract shall not have any rights under or in connection with it.
Industry

;
Category

;
State

;